Solara Active Pharma Sciences Ltd

Fri 18/09/2026,15:54:24 | NSE : SOLARA

₹742.050.35 (0.05%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 741.70

Previous Close

₹ 741.70

Volume

260084

Mkt Cap ( ₹ Cr)

₹ 3566.14

High

₹ 750.40

Low

₹ 730.00

52 Week High

₹ 774.00

52 Week Low

₹ 422.00

Book Value Per Share

₹ 264.83

Dividend Yield

0.00

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Solara Active Pharma Sciences Ltd

Your Vote -

Buy

88.24%

Hold

5.29%

Sell

6.47%

88.24%

170 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

720.80

94

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

94

Option Chain

Analyzes market sentiment, predicts Solara Active Pharma Sciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Solara Active Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM

    18 Sep 2026, 5:02PM Solara Active Pharma Sciences Limited has informed the Exchange regarding the Proceedings of Ninth Annual General Meeting held on September 18, 2026.

  • Solara Active Pharma - Intimation In Connection With The Receipt Of Rectification Order

    28 Aug 2026, 2:44PM Solara Active Pharma Sciences Limited has informed the exchange about intimation in connection with the receipt of Rectification Order

  • Solara Active Pharma - Updates

    28 Aug 2026, 2:42PM SOLARA: Solara Active Pharma Sciences Limited has informed the Exchange regarding Intimation in connection with the receipt of Rectification Order.

  • Solara Active Pharma - Copy of Newspaper Publication

    26 Aug 2026, 5:48PM SOLARA: Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication regarding the completion of dispatch of 9t

  • Solara Active Pharma - General Updates

    25 Aug 2026, 6:35PM Solara Active Pharma Sciences Limited has informed the Exchange about Business Responsibility and Sustainability Report for the financial year 2025-26

  • Solara Active Pharma - Business Responsibility and Sustainability Reporting (BRSR)

    25 Aug 2026, 6:35PM Business Responsibility and Sustainability Reporting for the financial year 2025-26.

  • Solara Active Pharma - Reg. 34 (1) Annual Report.

    25 Aug 2026, 6:28PM Annual Report for the financial year ended March 31, 2026

  • Solara Active Pharma - Shareholders meeting

    25 Aug 2026, 6:17PM Solara Active Pharma Sciences Limited has informed the exchange about the dispatch of Notice of Ninth Annual General Meeting (""AGM"") of the Company

  • Solara Active Pharma - Notice Of The Ninth Annual General Meeting

    25 Aug 2026, 6:16PM Solara Active Pharma Sciences Limited has informed the exchange about the dispatch of Notice of Ninth Annual General Meeting (AGM) of the Company sche

  • Solara Active Pharma - Copy of Newspaper Publication

    24 Aug 2026, 7:14PM SOLARA: Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Newspaper Publication with respect to the Ninth Annual Gen

  • Solara Active Pharma - Updates

    19 Aug 2026, 11:12AM Solara Active Pharma Sciences Limited has informed the Exchange regarding Conversion of partly paid-up Rights Equity Shares into fully paid-up equity

  • Solara Active Pharma - Conversion Of Partly Paid-Up Rights Equity Shares Into Fully Paid-Up Equity Shares In Relation To The

    19 Aug 2026, 11:13AM Conversion of Partly paid-up Rights Equity Shares into fully paid-up Equity shares in relation to the rights issue by the Company, upon receipt of Cal

  • Solara Active Pharma - ESOP/ESOS/ESPS

    18 Aug 2026, 1:58PM Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP options.

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    18 Aug 2026, 1:58PM Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP options

  • Solara Active Pharma - Updates

    7 Aug 2026, 3:51PM SOLARA: Solara Active Pharma Sciences Limited has informed the exchange regarding the update with respect to our intimation dated July 23, 2026, regar

  • Solara Active Pharma - Update With Respect To Our Intimation Dated July 23, 2026, Regarding Appointment Of CIO And SMP Of The

    7 Aug 2026, 3:35PM Solara Active Pharma Sciences Limited has informed the exchange regarding the update with respect to our intimation dated July 23, 2026, regarding app

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    29 Jul 2026, 11:35AM Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended June 30, 2026

  • Solara Active Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    29 Jul 2026, 11:35AM Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of Earnings conference call pertaining to financial results of the Co

  • Solara Active Pharma - Copy of Newspaper Publication

    24 Jul 2026, 4:36PM Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication providing extract of the unaudited financial resul

  • Solara Active Pharma - Updates

    24 Jul 2026, 2:13PM Solara Active Pharma Sciences Limited has informed the Exchange regarding Submission of Machine Readable copy of financial results for the quarter end

  • Solara Active Pharma - Submission Of Machine Readable Copy Of Financial Results For The Quarter Ended June 30, 2026

    24 Jul 2026, 2:13PM Solara Active Pharma Sciences Limited has informed the exchange regarding submission of Machine Readable copy of Financial results for the quarter end

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    23 Jul 2026, 7:17PM Solara Active Pharma Sciences Limited has informed the exchange about the Audio Recording of the Q1 FY 27 Earnings call held on July 23, 2026, at 16.0

  • Solara Active Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    23 Jul 2026, 7:17PM Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q1 FY27 Earnings Call held on July 23, 2026 at 16.00

  • Solara Active Pharma - Monitoring Agency Report

    23 Jul 2026, 5:27PM Monitoring Agency Report for the quarter ended June 30, 2026

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    23 Jul 2026, 5:27PM Monitoring Agency Report for the quarter ended June 30, 2026

  • Solara Active Pharma - Statement of deviation(s) or variation(s) under Reg. 32

    23 Jul 2026, 4:41PM Solara Active Pharma Sciences Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

  • Solara Active Pharma - Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30

    23 Jul 2026, 4:41PM Solara Active Pharma Sciences Limited has informed the exchange that there is no Deviation and Variation of funds raised through Rights Issue for the

  • Solara Active Pharma - ESOP/ESOS/ESPS

    23 Jul 2026, 4:34PM Solara Active Pharma Sciences Limited has informed the exchange regarding allotment of 2250 Equity Shares pursuant to exercise of ESOP Options.

  • Solara Active Pharma - General Updates

    23 Jul 2026, 1:52PM Solara Active Pharma Sciences Limited has informed the Exchange regarding the appointment of Mr. Ajit Manocha as Chief Information Officer (CIO) and d

  • Solara Active Pharma - Press Release

    23 Jul 2026, 1:36PM Solara Active Pharma Sciences Limited has informed the exchange regarding the Press release dated July 23, 2026 titled - Solara reports Strong Q1 27

  • Solara Active Pharma - Outcome of Board Meeting

    23 Jul 2026, 1:18PM Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia, to consider and approve the unaudited Standalone and Consolidate

  • Solara Active Pharma - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended

    23 Jul 2026, 1:18PM Solara Active Pharma Sciences Limited has informed the exchange regarding, inter alia, to consider and approve the unaudited Standalone and Consolidat

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    23 Jul 2026, 4:33PM Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 Equity Shares pursuant to exercise of ESOP options.

  • Solara Active Pharma - Intimation About Appointment Of Chief Information Officer (CIO)

    23 Jul 2026, 1:53PM Solara Active Pharma Sciences Limited has informed the exchange regarding the appointment of Mr. Ajit Manocha as Chief Information Officer (CIO) and d

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    23 Jul 2026, 1:30PM Solara Active Pharma Sciences Limited has informed the exchange regarding the Press Release dated July 23, 2026, titled - Solara reports Strong Q1'27

  • Solara Active Pharma - Unaudited Financial Results For The Quarter Ended June 30, 2026

    23 Jul 2026, 1:24PM Solara Active Pharma Sciences Limited has informed the exchange regarding, inter alia, to consider and approve the unaudited Standalone and Consolidat

  • Solara Active Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    20 Jul 2026, 8:20PM As of June 2026, 41.93% is owned by Indian Promoters and 58.07% by Public. <p align=justify> Top five Promoters holding highest number of shares of So

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 Jul 2026, 8:31PM Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Thursday, July 23, 2026 at

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 Jul 2026, 8:30PM Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Thursday, July 23, 2026 at

  • Solara Active Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Jul 2026, 8:26PM Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Thursday, July 23, 2026 at

  • Solara Active Pharma - Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing O

    16 Jul 2026, 8:00PM Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to

  • Solara Active Pharma - Copy of Newspaper Publication

    9 Jul 2026, 5:45PM Solara Active Pharma Sciences Limited has informed the Exchange about Copy of Newspaper Publication with respect to Final Reminder cum Forfeiture Noti

  • Solara Active Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2026, 2:00PM Solara Active Pharma Sciences Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants)

  • Solara Active Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jul 2026, 2:01PM The Company has informed the exchange about the Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the q

  • Solara Active Pharma - Approval Of The Reminder - Cum - Forfeiture Notice

    3 Jul 2026, 5:30PM Solara Active Pharma Sciences Limited has informed the exchange about the approval of the Reminder - cum- Forfeiture Notice, by the Rights Issue Commi

  • Solara Active Pharma - General Updates

    3 Jul 2026, 5:28PM Solara Active Pharma Sciences Limited has informed the Exchange about approval of Reminder-cum-Forfeiture Notice by the Rights Issue Committee members

  • Solara Active Pharma - Copy of Newspaper Publication

    26 Jun 2026, 6:15PM SOLARA: Copy of newspaper advertisement regarding the dispatch of notices to shareholders for the transfer of equity shares to the IEPF in respect of

  • Solara Active Pharma - General Updates

    26 Jun 2026, 6:04PM SOLARA: Dispatch of notices regarding the transfer of equity shares to the IEPF in respect of the unclaimed and unpaid dividend for the financial year

  • Solara Active Pharma - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Transfer Of Equity Shares Of The

    26 Jun 2026, 5:56PM Dispatch of notices regarding the transfer of equity shares to the IEPF in respect of the unclaimed and unpaid dividend for the financial year 2018-19

  • Solara Active Pharma - Trading Window

    25 Jun 2026, 6:08PM Solara Active Pharma Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)

  • Solara Active Pharma - Announcement under Regulation 30 (LODR)-Credit Rating

    23 Jun 2026, 6:32PM Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding Credit Rating received from Crisil Ratings Limited

  • Solara Active Pharma - Credit Rating

    23 Jun 2026, 6:29PM Solara Active Pharma Sciences Limited has informed the Exchange about Credit Rating

  • Solara Active Pharma

    6 Jul 2023 , 10:51AM Solara Active Pharma has agreed to raise funds through the issue of equity shares of FV of Rs. 10 not exceeding Rs. 450 Cr. by the way of rights issue to eligible equity shareholder of the company. We do not have coverage on it.

  • Solara Active Pharma successfully completes EU GMP Inspection

    13 Feb 2023 , 12:14PM Completion of the EU-GMP inspection at the Cuddalore facility of the Company

  • Stock Update: Solara Active Pharma Science

    12 Nov 2021 , 11:50AM Stock Update: Solara Active Pharma Science Q2FY22 Results Update

  • Solara Active Pharma Sciences Q2Fy22 results

    11 Nov 2021 , 5:14PM Solara Active Pharma Sciences Q2Fy22 results – Weak quarter, results missed estimates

  • Solara Active Pharma Sciences: Q1FY22 Results update

    5 Aug 2021 , 10:59AM Solara Active Pharma Sciences Ltd: Q1FY22 Results update - Healthy quarter; Robust outlook

  • Solara Active Pharma Sciences Q1FY2022

    4 Aug 2021 , 3:31PM Solara Active Pharma Sciences Q1FY2022: Healthy quarter; results miss estimates

  • Solara announces CEP for Ranitidine Hydrochloride drug substance restored by EDQM

    2 Jul 2021 , 3:31PM Solara is the first company to have its CEP restored among Ranitidine API manufacturers

  • Solara Active Pharma Sciences

    2 Jul 2021 , 3:19PM Solara Active Pharma Sciences: Has announced that the EDQM ( European Directorate for the Quality of Medicines & HealthCare) has restored is CEP for Ranitidine Hydrochloride drug substance (API). Solara had put in place robust manufacturing and quality processes to mitigate the risks of N-Nitroso Dimethylamine (NDMA) formation in the Ranitidine HCL API and subsequent submission of the pertinent data has fast-tracked the restoration of CEP by EDQM. Solara is the only company to have its CEP for Ranitidine hydrochloride restored, hence positive

  • Solara Active Pharma Sciences

    1 Jun 2021 , 10:27AM The government of India has given approval to four waitlisted firms under the Production Linked Incentive (PLI) scheme for domestic manufacturing of bulk drugs. It envisages setting up greenfield plants in four different target segments with a total outlay of Rs 6,940 crore for the period 2020-21 to 2029-30.Now the Government has approved the application of 4 wait listed players who were eligible under the scheme. These include Solara Active Pharma Sciences, while the other companies being approved are Rajasthan Antibiotics Ltd, Dhatri Lab Pvt Ltd and Vital Laboratories Pvt Ltd. The products for which the approvals have been given are 1 Cyclohexane Diacetic Acid, Meropenem, Ritonavir and Levofloxacin. The receipt of the approval for PLI scheme is positive for Solara Active Pharma Sciences.

  • Solara Active Pharma Sciences: Q4FY2021 Result Update

    7 May 2021 , 11:10AM Solara Active Pharma Sciences: Q4FY2021 Result Update - Strong quarter; Robust outlook

  • Stock update - Solara Active Pharma Sciences

    13 Apr 2021 , 11:03AM Stock update - Solara Active Pharma Sciences : Synergetic Merger, Earnings accretive

  • Solara Active Pharma Sciences board approves merger of Aurore Life sciences

    12 Apr 2021 , 12:12PM Solara Active, Aurore Life combine to create second largest Pure Play API / CRAMs company in India

  • Solara Active Pharma Sciences

    12 Apr 2021 , 10:18AM Solara Active Pharma Sciences (Solara): Board approves merger of Aurore Life sciences in an all-stock deal; combined entity to be pure play API company of scale with strong presence in key markets, broad product portfolio and could strengthen Solara’s CRAMS business. We believe the merger would be positive as both the business are synergistic and would open up multiple growth avenues and enable to achieve operational efficiencies

  • Solara Active Pharma Sciences

    19 Feb 2021 , 9:09AM As per media news, The promoters along with TPG capital are said to be looking for an exit from the company. The total promoters stake stands at 44% while TPG Group had a stake of around 15%. The stake sale is likely to trigger an open offer.

  • Solara Active Pharma Sciences : Stock Update

    9 Dec 2020 , 12:04PM Solara Active Pharma Sciences : Stock Update – Growth Levers Intact

  • Solara Active Pharma announces interim dividend

    11 Nov 2020 , 12:20PM Solara Active Pharma Sciences board declares interim dividend of Rs. 4

  • Solara Active Pharma reports good Q2 earnings

    30 Oct 2020 , 3:12PM Solara Active Pharma: Strong operating performance leads to PAT beat

  • Solara Active Pharma Sciences

    16 Sep 2020 , 10:08AM Promoters Pronomz Ventures released pledge of 13.18 lakh shares on September 10, 2020. Post the release the proportion of pledged shares stands at 4.7% of the total promoters holdings down from 13%. The release of the pledged shares is positive

  • New Idea - Solara Active Pharma Sciences

    14 Sep 2020 , 11:40AM New Idea - Solara Active Pharma Sciences – Viewpoint - Well placed to harness API opportunities

  • Solara Active Pharma completes USFDA inspection at SRC

    17 Dec 2018 , 11:35AM Solara Research Centre (SRC) completes USFDA Inspection with Zero 483s
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Solara Active Pharma Sciences Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 1870.47 1872.27 1936.8 2504.28 2551.62
Liabilities 1870.47 1872.27 1936.8 2504.28 2551.62
Equity 44.51 40.25 36 36 36
Gross Profit 186.68 203.84 -95.06 134.04 80.35
Net Profit -7.24 -1.08 -566.87 -22.21 -58.56
Cash From Operating Activities 152.89 212.8 110.95 156.17 -241.77
NPM(%) -0.52 -0.08 -43.98 -1.53 -4.61
Revenue 1368.98 1283.76 1288.92 1443.81 1268.34
Expenses 1182.3 1079.92 1383.98 1309.77 1187.99
ROE(%) -0.56 -0.08 -44.53 -1.74 -4.6

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
18 Aug 2021 3 30 0 1648.75
19 Nov 2020 4 40 0 1095.5
28 Jul 2020 2 20 0 502.4
06 Aug 2019 5 50 0 442.1

Peers

Other companies within the same industry or sector that are comparable to Solara Active Pharma Sciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 833.60 -0.58 21.08 422.73 -26.19 0.60
Lotus Eye Hospital and Institute Ltd 115.10 1.75 1644.29 1540.38 0.39 0.00
Vaishali Pharma Ltd 8.79 0.11 27.47 9663.33 15.42 0.00
Astec Lifesciences Ltd 726.70 -3.77 0.00 1650.44 -363.14 0.00

Company Info

Our Company was originally incorporated on February 23, 2017 under the Companies Act, 2013 as SSL Pharma Sciences Limited with the RoC. The name of the Company was changed to Solara Active Pharma Sciences Limited and a fresh certificate of incorporation was issued by the RoC on March 25, 2017. 2019 -Solara Active Pharma Sciences Limited said that, "it has successfully completed the US FDA inspection at the multi-product manufacturing facility at Cuddalore with ZERO 483s i 2021 -Solara Active Pharma approves acquisition of balance 10.77% stake in Sequent Penems 2023 -Solara Active Pharma Sciences completes WHO inspection at its Cuddalore facility. 2024 -The company issued rights shares of Rs. 10 in the ratio of 1:3 at a premium of Rs. 365 per share.

Our Company was originally incorporated on February 23, 2017 under the Companies Act, 2013 as SSL Pharma Sciences Limited with the RoC. The name of the Company was changed to Solara Active Pharma Sciences Limited and a fresh certificate of incorporation was issued by the RoC on March 25, 2017. 2019 -Solara Active Pharma Sciences Limited said that, "it has successfully completed the US FDA inspection at the multi-product manufacturing facility at Cuddalore with ZERO 483s i 2021 -Solara Active Pharma approves acquisition of balance 10.77% stake in Sequent Penems 2023 -Solara Active Pharma Sciences completes WHO inspection at its Cuddalore facility. 2024 -The company issued rights shares of Rs. 10 in the ratio of 1:3 at a premium of Rs. 365 per share.

Parent Organisation

Solara Active Pharma Sciences Ltd.

Founded

23/02/2017

Managing Director

Mr.Sandeep Shashikantha Rao

NSE Symbol

SOLARAEQ

FAQ